Table 1.
Clinical features of ankylosing spondylitis probands. Abbreviations: ASDAS-CRP, ankylosing spondylitis disease activity score—C reactive protein; BASDAI, Bath ankylosing spondylitis disease activity index; BASFI, Bath ankylosing spondylitis functional index; NSAIDs, nonsteroidal anti-inflammatory drugs.
| Feature | Value |
|---|---|
| n | 31 |
| Demographics | |
| Male Sex | 23 (74.2%) |
| Age (years) | 45.7 ± 7.1 |
| Race | |
| White | 20 (64.5%) |
| Asian | 8 (25.8%) |
| American Indian | 1 (3.2%) |
| Multiracial | 2 (6.5%) |
| Hispanic ethnicity | 3 (9.7%) |
| Treatment | |
| NSAIDs | 18 (58.1%) |
| Methotrexate | 1 (3.2%) |
| Etanercept | 5 (16.1%) |
| TNFi mAb | 11 (35.5%) |
| Secukinumab | 1 (3.2%) |
| Body mass index (mg/kg2 ± SD) | 25.5 ± 4.0 |
| BASDAI | 2.5 ± 2.3 |
| BASFI | 1.7 ± 2.4 |
| ASDAS-CRP | 1.8 ± 1.0 |